Growth hormone deficiency causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
*Disease name] may be caused by [cause1], [cause2], or [cause3].
*Common causes of [disease] include [cause1], [cause2], and [cause3].
*The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].
*The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.


==Causes==
==Causes==
There are many causes of GH deficiency. Some examples include:
* [[Mutation]]s of specific [[gene]]s (e.g., [[GHRHR]], GH1)
* [[Congenital malformation]]s involving the pituitary (e.g., [[septo-optic dysplasia]], posterior pituitary ectopia)
* Damage to the pituitary from incracranial disease (e.g., [[hydrocephalus]]),
* [[brain tumor|Intracranial tumors]] in or near the [[sella turcica]], especially [[craniopharyngioma]],
* Damage to the pituitary from [[radiation therapy]] to the head for [[leukemia]] or [[brain tumor]]s,
* Surgery in the area of the pituitary,
* [[autoimmunity|Autoimmune]] [[inflammation]] ([[hypophysitis]]),
* Severe [[head trauma]],
* [[Ischemia|Ischemic]] or hemorrhagic infarction from low blood pressure ([[Sheehan syndrome]]) or hemorrhage [[pituitary apoplexy]].


=== Congenital growth hormone deficiency: ===


==Causes==
==== Genetic ====
===Life-threatening Causes===
It is usually recognized by the presence of affected relatives and confirmed by molecular testing for the causative genes, which include ''POU1F1''''PROP-1'', and ''GH-1:''
*Life-threatening causes of [symptom/manifestation] include [cause1], [cause2], and [cause3].
* The ''POU1F1'' gene is responsible for pituitary-specific transcription of genes for GH, prolactin, thyrotropin, and the growth hormone releasing hormone (GHRH) receptor [11,12]. ''PROP1'' mutations result in failure to activate ''POU1F1/Pit1'' gene expression and probably cause pituitary hypoplasia and/or familial multiple pituitary hormone deficiencies.<ref name="pmid1977085">{{cite journal| author=Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG| title=Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. | journal=Nature | year= 1990 | volume= 347 | issue= 6293 | pages= 528-33 | pmid=1977085 | doi=10.1038/347528a0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1977085  }}</ref>
*[Cause] is a life-threatening cause of [disease].
* Deletions and mutations of ''GH1'' are the gene encoding GH, located on chromosome 17. Gene deletions, frameshift mutations, and nonsense mutations of ''GH1'' have been described as causes of familial GHD.
===Common Causes===
[Disease name] may be caused by:
*[cause1]
*[cause2]
*[cause3]
 
*[Disease name] is caused by an infection with [pathogen name].
*[Pathogen name] is caused by [pathogen name].
===Less Common Causes===
Less common causes of [[disease name]] include:
*[cause1]
*[cause2]
*[cause3]
 
===Genetic Causes===
*[Disease name] is caused by a mutation in the [gene name] gene.
 
===Causes by Organ System===
 
{|style="width:80%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | No underlying causes
|-
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Dental'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Dermatologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Ear Nose Throat'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Endocrine'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Environmental'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Genetic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Hematologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Iatrogenic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Infectious Disease'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Musculoskeletal/Orthopedic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Neurologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Nutritional/Metabolic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Obstetric/Gynecologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Oncologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Ophthalmologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Overdose/Toxicity'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Psychiatric'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Pulmonary'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Renal/Electrolyte'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Sexual'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Trauma'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Urologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Miscellaneous'''
|bgcolor="Beige"| No underlying causes
|-
|}


==== '''Structural causes''' ====
It is associated with midline craniofacial anomalies such as optic nerve hypoplasia causing agenesis of the hypothalamic-pituitary stalk. GHD is highly likely to be permanent in these patients.<ref name="pmid21602453">{{cite journal| author=Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society| title=Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2011 | volume= 96 | issue= 6 | pages= 1587-609 | pmid=21602453 | doi=10.1210/jc.2011-0179 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21602453  }}</ref>


===Causes in Alphabetical Order===
==== '''Organic causes''' ====
List the causes of the disease in alphabetical order.
GHD following brain surgery and radiation therapy for brain tumors. Permanent GHD is highly likely to be permanent in infants or young children.<ref name="pmid11836272">{{cite journal| author=Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ et al.| title=Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? | journal=J Clin Endocrinol Metab | year= 2002 | volume= 87 | issue= 2 | pages= 477-85 | pmid=11836272 | doi=10.1210/jcem.87.2.8216 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11836272  }}</ref>
{{columns-list|3|
* Cause 1
* Cause 2
* Cause 3
* Cause 4
* Cause 5
* Cause 6
* Cause 7
* Cause 8
* Cause 9
* Cause 10
}}


==References==
=== Adult growth hormone deficiency<ref name="pmid8772595">{{cite journal| author=Bates AS, Van't Hoff W, Jones PJ, Clayton RN| title=The effect of hypopituitarism on life expectancy. | journal=J Clin Endocrinol Metab | year= 1996 | volume= 81 | issue= 3 | pages= 1169-72 | pmid=8772595 | doi=10.1210/jcem.81.3.8772595 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8772595  }}</ref> ===
{{Reflist|2}}
* Treatment of a pituitary tumor including surgery and/or radiation
* An extra-pituitary tumor for example craniopharyngioma
* Sheehan syndrome


{{WH}}
==== '''Laron syndrome''' ====
{{WS}}
* It is the most common known cause of genetically-mediated GHI.<ref name="pmid5916640">{{cite journal| author=Laron Z, Pertzelan A, Mannheimer S| title=Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism? | journal=Isr J Med Sci | year= 1966 | volume= 2 | issue= 2 | pages= 152-5 | pmid=5916640 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5916640  }}</ref>
* is characterized by severe postnatal growth failure.
* It is caused by homozygous or compound heterozygous mutations in the growth hormone (GH) receptor gene; a variety of mutations have been identified, most of which affect the extracellular GH-binding region of the receptor.<ref name="pmid7565946">{{cite journal| author=Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N et al.| title=Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. | journal=N Engl J Med | year= 1995 | volume= 333 | issue= 17 | pages= 1093-8 | pmid=7565946 | doi=10.1056/NEJM199510263331701 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7565946  }}</ref>
* reflected by IGF-I and insulin-like growth factor-binding protein 3 (IGFBP-3) levels.<ref name="pmid18406284">{{cite journal| author=Rosenbloom AL, Guevara-Aguirre J| title=Lessons from the genetics of laron syndrome. | journal=Trends Endocrinol Metab | year= 1998 | volume= 9 | issue= 7 | pages= 276-83 | pmid=18406284 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18406284  }}</ref>
* Adult height does not correlate with genotype or with measures of height in family members.
* hyperlipidemia and episodes of hypoglycemia Data are conflicting on the risk of insulin resistance.<ref name="pmid21325617">{{cite journal| author=Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW et al.| title=Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. | journal=Sci Transl Med | year= 2011 | volume= 3 | issue= 70 | pages= 70ra13 | pmid=21325617 | doi=10.1126/scitranslmed.3001845 | pmc=3357623 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21325617  }}</ref>

Revision as of 19:44, 8 August 2017

Growth hormone deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Growth hormone deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Growth hormone deficiency causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Growth hormone deficiency causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Growth hormone deficiency causes

CDC on Growth hormone deficiency causes

Growth hormone deficiency causes in the news

Blogs on Growth hormone deficiency causes

Directions to Hospitals Treating Growth hormone deficiency

Risk calculators and risk factors for Growth hormone deficiency causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Causes

Congenital growth hormone deficiency:

Genetic

It is usually recognized by the presence of affected relatives and confirmed by molecular testing for the causative genes, which include POU1F1PROP-1, and GH-1:

  • The POU1F1 gene is responsible for pituitary-specific transcription of genes for GH, prolactin, thyrotropin, and the growth hormone releasing hormone (GHRH) receptor [11,12]. PROP1 mutations result in failure to activate POU1F1/Pit1 gene expression and probably cause pituitary hypoplasia and/or familial multiple pituitary hormone deficiencies.[1]
  • Deletions and mutations of GH1 are the gene encoding GH, located on chromosome 17. Gene deletions, frameshift mutations, and nonsense mutations of GH1 have been described as causes of familial GHD.

Structural causes 

It is associated with midline craniofacial anomalies such as optic nerve hypoplasia causing agenesis of the hypothalamic-pituitary stalk. GHD is highly likely to be permanent in these patients.[2]

Organic causes

GHD following brain surgery and radiation therapy for brain tumors. Permanent GHD is highly likely to be permanent in infants or young children.[3]

Adult growth hormone deficiency[4]

  • Treatment of a pituitary tumor including surgery and/or radiation
  • An extra-pituitary tumor for example craniopharyngioma
  • Sheehan syndrome

Laron syndrome

  • It is the most common known cause of genetically-mediated GHI.[5]
  • is characterized by severe postnatal growth failure.
  • It is caused by homozygous or compound heterozygous mutations in the growth hormone (GH) receptor gene; a variety of mutations have been identified, most of which affect the extracellular GH-binding region of the receptor.[6]
  • reflected by IGF-I and insulin-like growth factor-binding protein 3 (IGFBP-3) levels.[7]
  • Adult height does not correlate with genotype or with measures of height in family members.
  • hyperlipidemia and episodes of hypoglycemia Data are conflicting on the risk of insulin resistance.[8]
  1. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG (1990). "Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1". Nature. 347 (6293): 528–33. doi:10.1038/347528a0. PMID 1977085.
  2. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society (2011). "Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline". J Clin Endocrinol Metab. 96 (6): 1587–609. doi:10.1210/jc.2011-0179. PMID 21602453.
  3. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ; et al. (2002). "Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?". J Clin Endocrinol Metab. 87 (2): 477–85. doi:10.1210/jcem.87.2.8216. PMID 11836272.
  4. Bates AS, Van't Hoff W, Jones PJ, Clayton RN (1996). "The effect of hypopituitarism on life expectancy". J Clin Endocrinol Metab. 81 (3): 1169–72. doi:10.1210/jcem.81.3.8772595. PMID 8772595.
  5. Laron Z, Pertzelan A, Mannheimer S (1966). "Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?". Isr J Med Sci. 2 (2): 152–5. PMID 5916640.
  6. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N; et al. (1995). "Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group". N Engl J Med. 333 (17): 1093–8. doi:10.1056/NEJM199510263331701. PMID 7565946.
  7. Rosenbloom AL, Guevara-Aguirre J (1998). "Lessons from the genetics of laron syndrome". Trends Endocrinol Metab. 9 (7): 276–83. PMID 18406284.
  8. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW; et al. (2011). "Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans". Sci Transl Med. 3 (70): 70ra13. doi:10.1126/scitranslmed.3001845. PMC 3357623. PMID 21325617.